Gulnara Zh. Makhmudova

Gulnara Zh. Makhmudova

Auto-generated profile, based on publicly available information

Gulnara Zh. Makhmudova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Consilium Medicum
Verified
Journal Article
Open access
PDF file
MNMarina R. Nodel’
Marina R. Nodel’
GMGyulnara Zh. Mahmudova
Gyulnara Zh. Mahmudova
INIlmar Nikolas V. Niinoja
Ilmar Nikolas V. Niinoja
DRDmitry Vladimirovich Romanov
Dmitry Vladimirovich Romanov
Background. Depression is one of the most maladaptive manifestations of Parkinson's disease (PD). The relationship between depression and motor, cognitive, and other affective disorders in the early stages of PD remains debatable. Aim. To assess the frequency and severity of depression, to clarify the features of motor, affective disorders, and cognitive functions in patients with depression in the early stages of PD. Materials and methods. We observed 61 patients diagnosed with PD at stages III according to the HoehnYahr scale. The average age was 62.29.6 years, the average duration of PD was 2.51.6 years. Data were analyzed using the Unified PD Scale, the Beck Depression Inventory, the Apathy Scale, the Spielberger Anxiety Inventory, the PD Cognitive Assessment Scale (SCOPA-COG), the digital character substitution test (the symbolsnumbers test), the Montreal the Cognitive Function Assessment Scale (MoCA), the number-to-letter combination test, the Stroop test. Results. Symptoms of depression were detected in 48 (79%) patients with PD; 20 (33%) patients had subdepression, 24 (39%) had moderate and severe depression, and 4 (7%) had severe depression. In patients at stage I PD according to HoehnYahr, the frequency of moderate depression was 28%, at stage II (moderate and severe) 45%, and severe 10%. Patients with depression were characterized by a greater severity of motor symptoms, disturbances in daily activities, anxiety, apathy, as well as a decrease in executive cognitive functions. An inverse correlation was noted between the duration of depressive symptoms and deterioration in performance on tests to assess attention and control cognitive functions. Conclusion. Depression is a characteristic feature of the early stages of PD. Its frequency and severity increase from stage I to stage II of PD. Depression can be considered as an indicator of a more severe course of the disease, the progression of impairments in controlling cognitive functions. The possibility of assessing the prognosis of the course of the disease additionally substantiates the need to diagnose depression in patients with PD in the early stages of the disease.

3 October 2022 in Russian neurological Journal
Verified
Journal Article
Closed access
PDF file
МНМ. Р. Нодель
М. Р. Нодель
GMG. Zh. Mahmudova
G. Zh. Mahmudova
INI.N. V. Niinoja
I.N. V. Niinoja
DRDmitry Vladimirovich Romanov
Dmitry Vladimirovich Romanov
Introduction. Affective and cognitive disorders are characteristic manifestations of Parkinson’s disease (PD). The clinical assessment of this disorder in PD is assessed as a negative assessment of the quality of life (QoL) of patients. Issues related to motor, affective, cognitive communities with various aspects of QoL at the stage of PD require mandatory.Aim: to evaluate the associations between motor, affective, cognitive impairments and QoL indicators in patients in the early stages of PD.Results. Significant relationships were found between the motor aspects of QOL and affective and cognitive impairments: between the total assessment of AFLD, assessments of mobility/everyday activity of QoL and SSOBP (r = 0.45–0.49, p < 0.05), depression (r = 0.77, p < 0.05), apathy (r = 0.42, p < 0.05), trait anxiety (TA, r = 0.58, p < 0.05), visuospatial functions SCOPA (r = –0,34, p < 0.05), Stroop test 3 (r = 0.33, p < 0.05).There was a relationship between self-assessment of emotional well-being of QoL and affective, cognitive impairments: depression, TA (r = 0.73, 0.77, p < 0.05), state anxiety (SA), apathy (r = 0.52, r = 0.56, p < 0.05); SCOPA (r = –0.27, p < 0.05), interference index, Stroop test (r = 0.29, p < 0.05), 1 part TMT test (r = 0.31, p < 0.05). A relationship was found between self-assessment of social life and motor, affective disorders: SSOS (r = 0.38, p < 0.05), SA (r = 0.43, p < 0.05), depression (r = 0.48, p < 0.05), apathy (r = 0.57, p < 0.05).Conclusion. The significant role of depression, anxiety, apathy, cognitive impairments in self-assessment of motor disorders, decreased daily activity, deterioration of emotional and social aspects of QoL already in the early stages of PD justifies the need for diagnosis and treatment of these disorders in each patient. Taking into account the mutual influence of motor, affective and cognitive disorders, complex rehabilitation is required to improve the quality of life of patients.

20 November 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
MNM.R. Nodel
M.R. Nodel
TMT.A. Munasipova
T.A. Munasipova
GMG.ZH. Makhmudova
G.ZH. Makhmudova
ERElena Rasskazova
Elena Rasskazova
Parkinson’s disease (PD) is a progressive, multisystem neurodegenerative disease that significantly affects patients’ quality of life. The perception of the disease plays a crucial role in the psychological adaptation of patients. The poorly studied relationship between the self-assessment of the disease, neuropsychiatric disorders (depression, anxiety, apathy, cognitive disorders), and the quality of life of patients emphasizes the need for further research in this area. Objective. To evaluate the relationship of the perceptions of the disease with motor, cognitive, emotional impairment, and quality of life (QoL) in patients with early stages of PD. Material and methods. Fifty-three patients with Hoehn-Yahr stage 1—2 PD were examined (32 females, 21 males; age 60.8±7.68 years; disease duration 2.38±1.29 years). The study used Unified Parkinson’s Disease Rating Scale (UPDRS), Beck Depression Inventory, Starkstein Apathy Scale, State-Trait Anxiety Inventory, SCOPA-COG, MoCA, Control Function tests for executive functions, PDQ-39 Quality of Life Questionnaire, and the R. Moss-Morris Illness Perception Questionnaire. Results. Males had a higher self-assessment of treatment control; females and all patients at stage 1 had a more pronounced emotional representation (ER). ER was negatively correlated with the PD duration, indicators of cognitive functions (total MoCA and SCOPA-COG scores; control and visual-spatial functions), and positively correlated with motor disorders, depression, anxiety, and QoL reduction. Personal control and understanding of the disease correlated positively with cognitive function and negatively with apathy, depression, anxiety, and most QoL domains. Perceptions of serious consequences and the cyclical course of the disease were associated with a higher level of depression and anxiety and a decrease in QoL. Conclusion. Perceptions of the disease in patients with early stages of PD are closely related to cognitive and emotional impairment, as well as QoL. Psychological support should consider ER, perception of consequences, and control and understanding of the disease as a target for correction.

1 January 2019 in Psychiatry (Moscow) (Psikhiatriya)
Verified
Journal Article
Open access
INIlmar Nikolas V. Niinoja
Ilmar Nikolas V. Niinoja
DRDmitry Vladimirovich Romanov
Dmitry Vladimirovich Romanov
GMGulnara Zh. Makhmudova
Gulnara Zh. Makhmudova
MNMarina R. Nodel
Marina R. Nodel
Обоснование: депрессия наряду с когнитивными расстройствами является одним из наиболее распространенных немоторных психопатологических проявлений болезни Паркинсона (БП), однако проблема нозологической дифференциации и типологии аффективных расстройств при БП до настоящего времени остается нерешенной. Цель: психопатологическая и нозологическая дифференциация депрессии при БП с определением модуса ассоциации аффективных и неврологических расстройств. Пациенты и методы исследования: на базе клиники нервных болезней им. А.Я. Кожевникова УКБ №3 ФГАОУ ВО Первый МГМУ им. И.М. Сеченова (Сеченовский Университет) обследовано 28 пациентов (22 женщины, 6 мужчин, средний возраст 64,4 ± 9,4 года) с верифицированными диагнозами депрессии и БП. Наряду с психопатологическим методом использованы психометрические шкалы оценки депрессии (шкала депрессии Гамильтона — HADS-21) и когнитивных функций (краткое нейропсихологическое обследование когнитивной сферы — КНОКС, краткая шкала оценки психического статуса — MMSE), а также унифицированная шкала оценки болезни Паркинсона (УШОБП). Результаты: предложена клиническая типология депрессий при БП, отражающая закономерности формирования, а также ассоциацию аффективного и неврологического расстройства. Выделены два варианта депрессивных расстройств, каждый из которых включает два клинических подтипа: (I) депрессии, непосредственно ассоциированные с БП, включающие (1) нозогенные депресии и (2) органические депрессии; и (II) депрессии, манифестирующие независимо от БП, включающие (3) реактивные депрессии и (4) эндогенные депрессии. Кроме того, выделена представленная казуистическими наблюдениями (3 случая) группа эндоформных депрессивных состояний. Заключение: установленная клинико-нозологическая гетерогенность депрессий при БП, их психопатологическая структура и модус интеракции с БП расширяют возможности дифференциальной диагностики и, соответственно, определения индивидуального прогноза и подбора персонализированной терапии.